KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Cash: 2015-2025

Historic Change in Cash for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $239.0 million.

  • Medpace Holdings' Change in Cash rose 63.71% to $239.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$371.5 million, marking a year-over-year decrease of 166.15%. This contributed to the annual value of $424.0 million for FY2024, which is 95.22% up from last year.
  • As of Q3 2025, Medpace Holdings' Change in Cash stood at $239.0 million, which was up 160.50% from -$395.1 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Change in Cash ranged from a high of $239.0 million in Q3 2025 and a low of -$395.1 million during Q2 2025.
  • Over the past 3 years, Medpace Holdings' median Change in Cash value was $56.1 million (recorded in 2023), while the average stood at $23.4 million.
  • In the last 5 years, Medpace Holdings' Change in Cash plummeted by 786.72% in 2022 and then surged by 5,579.29% in 2023.
  • Medpace Holdings' Change in Cash (Quarterly) stood at $62.9 million in 2021, then tumbled by 104.36% to -$2.7 million in 2022, then surged by 5,579.29% to $150.2 million in 2023, then plummeted by 91.66% to $12.5 million in 2024, then surged by 63.71% to $239.0 million in 2025.
  • Its Change in Cash was $239.0 million in Q3 2025, compared to -$395.1 million in Q2 2025 and -$228.0 million in Q1 2025.